LSTA

Lisata Therapeutics Inc

• TipRanks·4d ago

  Lisata Therapeutics Delays Tender Offer Launch in Merger

• Reuters·4d ago

  LISATA THERAPEUTICS INC - CO AND KUVA LABS EXTEND TENDER OFFER DEADLINE TO APRIL 13, 2026 - SEC FILING

• Reuters·4d ago

  Lisata-Kuva Labs merger deal extends tender offer launch deadline to 26 business days

• Reuters·03/12 20:23

  Lisata Therapeutics FY 2025 net loss narrowed 17% to USD 16.59 million

• TipRanks·03/09 12:08

  Lisata Therapeutics to Be Acquired by Kuva Labs

• Benzinga·03/09 08:54

  Why Lisata Therapeutics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

• Benzinga·03/09 06:42

  Reported Friday, Lisata Therapeutics To Be Taken Private By Kuva Labs In A Deal Offering Stockholders $5.00 Per Share Plus A $1.00 Contingent Value Right Per Share

• NASDAQ·03/07 04:39

  Lisata Therapeutics Agrees To Be Taken Private By Kuva Labs

• TipRanks·03/06 23:25

  Lisata Therapeutics to be acquired by Kuva Labs for $5 per share cash plus CVR

• Dow Jones·03/06 23:19

  *Lisata Therapeutics: Transaction Expected to Close in 2Q >LSTA

• Dow Jones·03/06 23:19

  *Lisata Therapeutics: Board of Directors Unanimously Approved the Transaction and Recommends That Stockholders Tender Their Shrs >LSTA

• Dow Jones·03/06 23:19

  *Lisata Therapeutics: Each Lisata Stockholder to Receive $5.00 per Shr in Cash Payable at Closing Plus One Contingent Value Right for a Potential Additional Cash Payment of $1.00 per Shr >LSTA

• Reuters·03/06 23:15

  Kuva Labs to acquire Lisata Therapeutics for $5 per share plus CVR

• Reuters·03/06 23:15

  LISATA THERAPEUTICS INC - KUVA TO BUY LISATA FOR $5.00 PER SHARE IN CASH PLUS ONE CVR PER SHARE

• Reuters·03/06 23:15

  LISATA THERAPEUTICS INC - TO BE DELISTED FROM NASDAQ AND DEREGISTER AS REPORTING COMPANY AFTER DEAL CLOSE